AusPAR: Retapamulin

Australian Public Assessment Report

AusPAR

AusPAR: Retapamulin [PDF, 1.3 MB]

AusPAR: Retapamulin [Word, 2.09 MB]

Attachment: Product Information: Retapamulin [PDF, 135.06 KB]

Attachment: Product Information: Retapamulin [Word, 73.5 KB]

Attachment: Extract from Clinical Evaluation Report: Retapamulin [PDF, 1.57 MB]

Attachment: Extract from Clinical Evaluation Report: Retapamulin [Word, 2.37 MB]

Device/Product Name

Altargo

Active ingredients

Retapamulin

AusPAR Date

11 November 2013

Published

23 December 2013

Submission Number

PM-2012-01489-3-2

Submission Type

New chemical entity

Decision

Approved